Fund Evaluator:
BlackRock Health Sciences Opps R (BHSRX)
Follow This Fund
Best Performing in Health Over the Last Year
| 62.8% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 62.6% | Fidelity Advisor Biotechnology I (FBTIX) |
| 56.2% | Eventide Healthcare & Life Sciences N (ETNHX) |
| 53.5% | Fidelity Select Biotechnology (FBIOX) |
| 49.5% | Fidelity Select Pharmaceuticals Port (FPHAX) |
Fund Details
BlackRock Health Sciences Opps R Overview
BlackRock Health Sciences Opps R (BHSRX) is an actively managed Sector Equity Health fund. BlackRock launched the fund in 2011.
The investment seeks to provide long-term growth of capital. The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.
About BlackRock Health Sciences Opps R (BHSRX)
There are 2 members of the management team with an average tenure of 14.60 years: Xiang Liu (2020), Erin Xie (2003). Management tenure is more important for actively managed funds than passive index funds.
The fund has 2 primary benchmarks: Russell 3000 TR USD index with a weighting of 100% and Russell 3000 Ind/HC TR USD index with a weighting of 100%. BlackRock Health Sciences Opps R has 159 securities in its portfolio. The top 10 holdings constitute 53.0% of the fund’s assets. The fund meets the SEC requirement of being classified as a diversified fund. The fund is not considered to have an ESG focus with its investment selection and management.
BlackRock Health Sciences Opps R is part of the Equity global asset class and is within the Sector Equity fund group. BlackRock Health Sciences Opps R has 4.3% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 94.4%. There is 4.3% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). BlackRock Health Sciences Opps R has 1.1% of the portfolio in cash.
Assets Under Management
The fund has $213 million in total assets, which is below the $884 million average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
BHSRX Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The BlackRock Health Sciences Opps R expense ratio is high compared to funds in the Health category. BlackRock Health Sciences Opps R has an expense ratio of 1.44%, which is 19% higher than its category average, making the fund expense ratio grade a D. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. BlackRock Health Sciences Opps R has a portfolio turnover rate of 43%, indicating that holds its assets around 0.0 years. By way of comparison, the average portfolio turnover is 61% for the Health category.
Recently, in the month of July 2026, BlackRock Health Sciences Opps R returned 0.4%, which earned it a grade of B, as the Health category had an average return of -0.4%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all funds in that category.
BlackRock Health Sciences Opps R has a trailing yield of 0.10%, which is below the 0.39% category average. The fund normally distributes its income annually and its capital gains annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
BlackRock Health Sciences Opps R Grades
Year to date, the fund has returned 4.6%, 2.5 percentage points worse than the category, which translates into a grade of D. The fund has returned 24.6% over the past year (grade of F), 8.4% over the past three years (grade of D) and 4.3% per year over the past five years (grade of C) and 9.5% per year over the past 10 years (grade of C).
For more mutual fund grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about BlackRock Health Sciences Opps R, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
BHSRX Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| BHSRX Return (NAV) | 0.4% | 10.4% | 24.6% | 8.4% | 4.3% | 9.5% |
| BHSRX Grade | B | C | F | D | C | C |
| +/- Category | 0.7% | -0.3% | -9.3% | -2.3% | -0.7% | 0.2% |
| Health Avg | -0.4% | 10.7% | 33.9% | 10.7% | 5.0% | 9.3% |
| BHSRX Tax Cost Ratio | na | na | 3.5% | 2.5% | 2.2% | 1.7% |
BHSRX Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| BHSRX Return (NAV) | 4.6% | 15.6% | 3.5% | 3.2% | -6.3% | 11.4% | 19.1% | 24.9% | 7.6% | 24.4% | -6.4% |
| BHSRX Grade | D | D | C | D | B | C | D | D | A | B | B |
| +/- Category | -2.5% | -5.1% | 1.0% | -2.4% | 3.1% | 2.7% | -5.4% | -3.5% | 7.3% | 1.0% | 4.5% |
| Health Avg | 7.1% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 13.4% |
| Total Risk Index: | 1.09 - Above Average |
| Category Risk Index: | 0.84 - Low |
| Category Risk Grade: | A (5% Rank) |
| Beta: | 0.51 |
| R-Squared: | 23% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Value |
| Bond Investment Style: | na |
| Yield: | 0.1% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $6086 Mil |
| Fund Total Assets: | $ 214 Mil |
| Share Class Type: | Retirement |
| Portfolio Turnover: | 43% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 23.0 years | |||
| Average Tenure: 14.6 years | |||
| Managers (Year): Xie Erin (2003), Liu Xiang (2020) | |||
Portfolio Composition (as of 6/30/26)
| # of Holdings: | 159 |
| % in Top 10 Holdings: | 53.0% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 4.3% |
Portfolio Allocation |
|
| Domestic Stock: | 94.4% |
| Foreign Stock: | 4.3% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.3% |
| Cash: | 1.1% |
Purchase Information
| Fund Family: | BlackRock |
| Phone Number: | 800-441-7762 |
| Website: | www.blackrock.com |
| Status: | Open |
| Inception Date: | September 12, 2011 |
| Min. Initial Purchase: | $ 100 |
| Min. Initial IRA Purchase: | $ 100 |
| True No-Load: | No |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.50% |
Expenses and Fees | |
| Expense Ratio (%): | 1.44% ( Rating : High ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | BlackRock Health Sciences Opps Inv A |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
